Antiinfectives for systemic use

Filters
Category
Release Form
Primary Package
Status
Dossier Type
Search

Antiinfectives for systemic use

Aciclovir

Antiinfectives for systemic use

Tablets

Tablets

200mg, 400mg, 800mg

Blister, Rx, EU CTD
More Less

Dioxydine

Antiinfectives for systemic use

Sterile Solution

Sterile Solution

10mg/mL: 10mL

Ampoule, Rx, CTD
More Less

Enisamium iodide

Antiinfectives for systemic use

Capsules solid Film-coated Tablets Syrup

Capsules solid

500mg

Blister, OTC, Original
Film-coated Tablets

125mg, 250mg

Blister, OTC, Original
Syrup

10mg/mL: 100mL

Container, OTC, Original
More Less

Inosine pranobex

Antiinfectives for systemic use

Syrup Tablets

Syrup

50mg/mL: 100mL
100mg/mL: 100mL

Container, Rx, CTD
Tablets

500mg

Blister, Rx, CTD
More Less

Itraconazole

Antiinfectives for systemic use

Capsules solid

Capsules solid

100mg

Blister, Rx, CTD
More Less

Moxifloxacin

Antiinfectives for systemic use

Solution for Infusion

Solution for Infusion

400mg/250mL

Vial, Rx, EU CTD
More Less

Terbinafine

Antiinfectives for systemic use

Tablets

Tablets

250mg

Blister, Rx, CTD
More Less

Valaciclovir

Antiinfectives for systemic use

Film-coated Tablets

Film-coated Tablets

500mg

Blister, Rx, CTD
More Less

Farmak International offers a broad category of products formulated to prevent and treat infections stemming from microscopic pathogens. We deliver antiinfectives and other drugs to pharmaceutical companies, distributors, hospitals, procurement organizations, and healthcare partners.

Systemic Antiinfective Product Portfolio

Our systemic anti-infective product portfolio encompasses a comprehensive, well-balanced range of antimicrobial agents and pharmaceutical products in all broad pharmacological categories, classified by the type of pathogenic microorganism they are developed to treat. As a systemic antiinfectives supplier and manufacturer, we offer a CTD-ready portfolio:

  • antibacterial agents, such as Moxifloxacin, a pharmaceutical in the quinolone antibiotic class, and Dioxydine, belonging to the quinoxaline di-N-oxide class;
  • antiviral agents for systemic infections, such as Aciclovir, Valaciclovir, Enisamium iodide, and Inosine pranobex;
  • antifungal agents for invasive mycoses (Itraconazole and Terbinafine).

As a broad-spectrum antibiotics supplier and manufacturer, we also deliver all-around therapy options. Our medicines are available as topical creams or sprays, film-coated tablets, solid capsules, syrups, and solutions for infusions.

Hospital & Clinical Applications

Hospital and clinical applications of infectious disease medications are aimed at prevention and treatment. They interrupt the spread of infections and ensure optimal patient recovery. The choice depends on individual resistance patterns. The applications include the following:

  • treatment of systemic bacterial infections and sepsis (Moxifloxacin and Dioxydine);
  • pneumonia and respiratory tract infections (Moxifloxacin, Dioxydine, Aciclovir, and Valaciclovir);
  • support for antimicrobial stewardship programs, which are intended to cure infections and reduce drug resistance and adverse events.

Our products can be used for empirical and targeted therapies. As an antiviral drugs supplier, we understand that there are cases when empirical treatment based on clinical signs is critically required before the harmful microorganism is identified in the laboratory. Pathogen-directed medications selected after diagnostics identifying the harmful microorganism improve efficacy and reduce host toxicity. 

Product Specifications & Formulations

Being a generic antibiotics supplier, we offer both specialised drugs requiring a prescription and those widely available in retail pharmacies globally. Our products from this category have multiple routes of administration:

  • injectable solutions (IV, IM);
  • oral formulations (tablets, capsules, suspensions).

Tablets and capsules are arranged in blisters. Syrups come in containers. Solutions are marketed in vials or ampules. We offer different package sizes. Medications are available in different concentrations or amounts of active ingredient per unit, which allows physicians to tailor treatment to a patient’s needs and weight. As an IM and IV antibiotics supplier, we offer a CTD-ready portfolio.

Framak International is a pharmaceutical distributor in Europe and across the globe with production facilities and storage capacities in Ukraine and Spain. We adhere to strict storage requirements under the GDP guidelines. We test the drug stability to provide our partners with specific stability-related data to establish safe storage conditions and expiration dates.

Quality Standards & Regulatory Compliance

When marketing antibacterial, antiviral, and antifungal medications, a distributor must ensure strict regulatory compliance, because these products are classified as pharmaceuticals. At Farmak Group, we adhere to legal frameworks and hold EU GMP certification.

We prepare a comprehensive package of documents that describe the medicine’s quality, safety, and efficacy. Our partners can submit such complete regulatory dossiers to local health authorities and gain regulatory approval and official legal permission to sell the drugs. Also, we offer antimicrobial resistance monitoring data for efficient systemic infection treatment.

Reliable Antiinfective Supply Partnership

Our hospital anti-infectives are medications used to prevent and treat infections within healthcare facilities. This broad category includes systemic drugs (antibiotics, antivirals, and antifungals) and topical agents (antiseptics and disinfectants) specifically formulated or designated for use in inpatient and clinical settings to manage both community-acquired illnesses and dangerous healthcare-associated infections. The benefits of partnership with Farmak International:

  • rapid deliveries through distribution networks across Europe, MENA, and Central Asia;
  • continuity of care options in all therapeutic categories;
  • flexible order quantities and tailored MOQs that will allow customers to reduce cash outlay and inventory risk;
  • competitive institutional antibiotic supply pricing;
  • guaranteed short lead times for urgent orders and transparent tracking.

Also, Farmak International provides technical and regulatory support and helps partners expand their product range and access regulatory and technical expertise. By working together, we’ll improve medication availability and, as a result, optimise patient care across the globe.